Leading Biotech Firm Selects Amadeus For Global Corporate Compliance Initiative
Quebec City, March 30, 2005 - A madeus International inc. “Amadeus” (TSX-V: AML), premier global provider of compliance process control software solutions, today announced that one the world’s leading biotechnology companies has selected Amadeus’ eQCM® as their standard compliance platform for their strategic global compliance initiative . Amadeus’ eQCM® delivers integrated process control and real time compliance business intelligence to facilitate access and control of all compliance processes information across the globe.
This recent sale represents a significant milestone achievement that affirms Amadeus’ strategic product direction and accentuates the market value of our compliance solutions. Prior to the selection of Amadeus' eQCM® , the global biotech manually controlled and managed all global processes such as audits, corrective and preventive actions, non-conformances, deviations and other regulated processes. The company had previously deployed expensive, departmental solutions that provided marginal remedies but did not provide consistent control for regulated processes across the organization. In a strategic move to higher levels of compliance maturity, the company envisioned a system that could consistently control all of its disparate compliance processes and deliver real time status updates to fulfill its management control regulatory obligations more effectively.
According to the company’s director of Global Corporate Compliance, "Our intent through this initiative is to harmonize our compliance processes and improve our ability to access status updates for all compliance activities on demand. We reviewed many systems that offered point solutions to address specific compliance issues. Amadeus’ solution offered a comprehensive approach to address our needs with a system that easily fit within our existing technology infrastructure without custom programming. We felt that their integrated process control approach moved us a level above point solutions and was a clear differentiator that we believe will enhance our ability to achieve sustained compliance and provide strategic business benefit to our global operations."
Amadeus’ eQCM® has raised the bar and redefined the systems approach to compliance accentuating regulatory process control as organizations evolve from departmental to a more strategic approach to compliance. The Amadeus eQCM® platform couples powerful process workflow capability with business intelligence, regulatory document management, reporting, and analysis. As organizations bring people, processes, and technology to bear for their compliance initiatives, Amadeus leads the way in delivering solutions that truly help organizations achieve regulatory excellence.
According to AMR Research, firms across the globe will spend $15.5B per year on a wide range of compliance programs. From this amount, more than $1B per year will be spent by life science companies in their regulatory compliance initiatives.
About Amadeus
Amadeus, a division of Xybion, is a leading provider of Enterprise Quality and Compliance Management software solutions. For over 14 years, customers in the Life Sciences, Manufacturing, Financial Services and other industries have automated their compliance and quality processes using Amadeus software platforms. Its flagship product, eQCM®, offers an integrated and very cost effective solution for enterprise governance, risk management, quality and compliance management. Amadeus’s solutions have been implemented in more than 100 companies in North America and Europe. (www.amadeussolutions.com)
Information
Amadeus Inc.
400 Jean-Lesage Boulevard, Suite 500
Quebec City , QC , G1K 8W1 , Canada
Isabelle Rivoal
Communications Manager
Phone: (418) 525-0606 ext. 2231
